WHO board of trustees calls for gene editing tools to be imparted to more poorer countries Kumar Jeetendra | July 12, 2021 A World Health Organization (WHO) committee said on Monday that human genome editing technologies to treat serious disease should be shared more generously, to allow poorer nations to benefit from the highly dynamic scientific field. “WHO should work with others to encourage relevant patent holders to help ensure equitable access to human genome editing interventions,” …
China says ”shocked” by WHO plan for COVID source: Study Kumar Jeetendra | July 22, 2021 A senior Chinese health official said Thursday he was shocked by the World Health Organisation’s plan for the second phase of a COVID-19 origins study. National Health Commission Vice Minister Zeng Yixin dismissed the lab leak theory as a rumor running counter to common sense. The head of the WHO acknowledged last week that it …
Hard-won increases in risk as Delta variant spreads: WHO Kumar Jeetendra | August 1, 2021 The world is at risk of losing hard-won gains in fighting COVID-19 as the highly transmissible Delta variant spreads, but WHO-approved vaccines remain effective, the World Health Organization said on Friday. The U.S. Centers for Disease Control and Prevention (CDC) has described the Delta variant of the coronavirus as being as transmissible as chickenpox and …
WHO calls for ban on COVID-19 vaccine booster dose Kumar Jeetendra | August 4, 2021 The World Health Organization is calling for a moratorium on COVID-19 vaccine boosters until at least the end of September, its head Tedros Adhanom Ghebreyesus said on Wednesday. The move was to enable that at least 10% of the population of every country was vaccinated, Tedros said. “I understand the concern of all governments to …
WHO announces a global decrease in COVID-19 cases that are new Kumar Jeetendra | September 22, 2021 The number of new COVID-19 cases continued to fall last week, with 3.6 million new cases reported globally, down from 4 million new infections the previous week, the World Health Organization said. Last week’s drop marked the first substantial decline for more than two months, with falling COVID-19 cases in every world region. In its …
Mikromol feature product: Bicalutamide- A non-steroidal antiandrogen (NSAA) Kumar Jeetendra | July 4, 2022 Antiandrogens work by blocking the androgen receptor and/or inhibiting or suppressing androgen production. Bicalutamide competes with androgen to bind to androgen receptors, consequently blocking the action of adrenal and testicular androgens that stimulate the growth of normal and malignant prostatic tissue. Introduction: Bicalutamide was first discovered in the 1980s and patented in 1982. It is …
